Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
began, career, cGMP, curtail, curtailing, delinquent, displaying, host, led, outbreak, outpatient, pandemic, pose, repayment, simultaneously, situation, sixteen, source, spread, staffing, Subtopic, thirteen
Removed:
accounted, Amir, amortization, Anton, cardiovascular, coating, commodity, comparative, COO, deferral, Delshad, derivative, Division, extinguishment, fiduciary, fifteen, fourth, Hall, Heshmatpour, Holding, Implant, Imricor, INCSTAR, invasive, knee, leasing, lessee, MBA, Microvena, minimally, offset, Origen, Orthofix, osteoporotic, practical, pre, prolong, retroactive, retrospective, serving, Seton, Spineology, Steve, subscription, toLiquidity, unamortized, Villanova
Filing tables
Filing exhibits
BBLG similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-212890) of Bone Biologics Corporation of our report dated April 15, 2021 related to the financial statements of Bone Biologics Corporation for the years ended December 31, 2020 and 2019 included in this Annual Report on Form 10-K for the year ended December 31, 2020.
Weinberg and Company, P.A.
Los Angeles, California
April 15, 2021